A Mounjaro, which uses the same ingredient (tirzepatide) and is made by the same company (Eli Lilly), is for people with diabetes
In 2026, it feels like everyone is taking a GLP-1or at least thinking about it
It does not hold marketing authorization as a medicinal product under pharmaceutical law
In a statement published on 11 December 2025, Eli Lilly reported results from its TRIUMPH-4 trial, which involved 445 participants aged over 18 years with a BMI of 27.0kg/m who met American College of Rheumatology Criteria for knee osteoarthritis
The most commonly reported side effects are gastrointestinal in nature, reflecting the medication's mechanism of action on the digestive system
We get into the practical questions Im already hearing: what the devices will look like, whether dosing will feel the same, and how switching between products might affect different patients